Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study - Comi, G; Pulizzi, A; Rovaris, M (Lancet, 2008)
et al.